Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Optimized emulgels with Levofloxacin effectively treat eye infections with prolonged drug release and safety.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Tangent screens help detect visual field defects from vigabatrin.

Sodium valproate can cause severe liver disease and side effects, sometimes leading to death.

The treatment is safe and shows promise for metastatic breast cancer.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Levofloxacin may cause skin discoloration and hair loss as side effects.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Scurvy, caused by lack of vitamin C, can be mistaken for other conditions but improves with vitamin C supplements.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Feeding sheep up to 30% Leucaena leaf meal does not harm their blood metabolites and thyroid hormones.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Sodium valproate can cause low platelets and hair loss.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

The cat improved with treatment but had kidney issues from long-term allopurinol use.